What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Digestive Disorder

PUBLISHER: QYResearch | PRODUCT CODE: 1859998

PUBLISHER: QYResearch | PRODUCT CODE: 1859998

Mesalazine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

PUBLISHED: October 14, 2025

PAGES: 130 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

The global market for Mesalazine was estimated to be worth US$ 190 million in 2024 and is forecast to a readjusted size of US$ 247 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Mesalazine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

In 2024, global Mesalazine sales reached approximately 5,417 tons, with an average global market price of around US$ 35.0 per kg.

The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.

With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.

Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

This report aims to provide a comprehensive presentation of the global market for Mesalazine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mesalazine by region & country, by Purity, and by Application.

The Mesalazine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine.

Market Segmentation

By Company

PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)

Segment by Purity

Purity >= 97%
Purity >= 98%
Purity >= 99%

Segment by Application

Tablets
Capsules
Granule
Suppository
Enema
Others

By Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Mesalazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Mesalazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Mesalazine in country level. It provides sigmate data by Purity, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

1 Market Overview

1.1 Mesalazine Product Introduction
1.2 Global Mesalazine Market Size Forecast
- 1.2.1 Global Mesalazine Sales Value (2020-2031)
- 1.2.2 Global Mesalazine Sales Volume (2020-2031)
- 1.2.3 Global Mesalazine Sales Price (2020-2031)
1.3 Mesalazine Market Trends & Drivers
- 1.3.1 Mesalazine Industry Trends
- 1.3.2 Mesalazine Market Drivers & Opportunity
- 1.3.3 Mesalazine Market Challenges
- 1.3.4 Mesalazine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Mesalazine Players Revenue Ranking (2024)
2.2 Global Mesalazine Revenue by Company (2020-2025)
2.3 Global Mesalazine Players Sales Volume Ranking (2024)
2.4 Global Mesalazine Sales Volume by Company Players (2020-2025)
2.5 Global Mesalazine Average Price by Company (2020-2025)
2.6 Key Manufacturers Mesalazine Manufacturing Base and Headquarters
2.7 Key Manufacturers Mesalazine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Mesalazine
2.9 Mesalazine Market Competitive Analysis
- 2.9.1 Mesalazine Market Concentration Rate (2020-2025)
- 2.9.2 Global 5 and 10 Largest Manufacturers by Mesalazine Revenue in 2024
- 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine as of 2024)
2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Purity

3.1 Introduction by Purity
- 3.1.1 Purity >= 97%
- 3.1.2 Purity >= 98%
- 3.1.3 Purity >= 99%
3.2 Global Mesalazine Sales Value by Purity
- 3.2.1 Global Mesalazine Sales Value by Purity (2020 VS 2024 VS 2031)
- 3.2.2 Global Mesalazine Sales Value, by Purity (2020-2031)
- 3.2.3 Global Mesalazine Sales Value, by Purity (%) (2020-2031)
3.3 Global Mesalazine Sales Volume by Purity
- 3.3.1 Global Mesalazine Sales Volume by Purity (2020 VS 2024 VS 2031)
- 3.3.2 Global Mesalazine Sales Volume, by Purity (2020-2031)
- 3.3.3 Global Mesalazine Sales Volume, by Purity (%) (2020-2031)
3.4 Global Mesalazine Average Price by Purity (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application
- 4.1.1 Tablets
- 4.1.2 Capsules
- 4.1.3 Granule
- 4.1.4 Suppository
- 4.1.5 Enema
- 4.1.6 Others
4.2 Global Mesalazine Sales Value by Application
- 4.2.1 Global Mesalazine Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Mesalazine Sales Value, by Application (2020-2031)
- 4.2.3 Global Mesalazine Sales Value, by Application (%) (2020-2031)
4.3 Global Mesalazine Sales Volume by Application
- 4.3.1 Global Mesalazine Sales Volume by Application (2020 VS 2024 VS 2031)
- 4.3.2 Global Mesalazine Sales Volume, by Application (2020-2031)
- 4.3.3 Global Mesalazine Sales Volume, by Application (%) (2020-2031)
4.4 Global Mesalazine Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Mesalazine Sales Value by Region
- 5.1.1 Global Mesalazine Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Mesalazine Sales Value by Region (2020-2025)
- 5.1.3 Global Mesalazine Sales Value by Region (2026-2031)
- 5.1.4 Global Mesalazine Sales Value by Region (%), (2020-2031)
5.2 Global Mesalazine Sales Volume by Region
- 5.2.1 Global Mesalazine Sales Volume by Region: 2020 VS 2024 VS 2031
- 5.2.2 Global Mesalazine Sales Volume by Region (2020-2025)
- 5.2.3 Global Mesalazine Sales Volume by Region (2026-2031)
- 5.2.4 Global Mesalazine Sales Volume by Region (%), (2020-2031)
5.3 Global Mesalazine Average Price by Region (2020-2031)
5.4 North America
- 5.4.1 North America Mesalazine Sales Value, 2020-2031
- 5.4.2 North America Mesalazine Sales Value by Country (%), 2024 VS 2031
5.5 Europe
- 5.5.1 Europe Mesalazine Sales Value, 2020-2031
- 5.5.2 Europe Mesalazine Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
- 5.6.1 Asia Pacific Mesalazine Sales Value, 2020-2031
- 5.6.2 Asia Pacific Mesalazine Sales Value by Region (%), 2024 VS 2031
5.7 South America
- 5.7.1 South America Mesalazine Sales Value, 2020-2031
- 5.7.2 South America Mesalazine Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
- 5.8.1 Middle East & Africa Mesalazine Sales Value, 2020-2031
- 5.8.2 Middle East & Africa Mesalazine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Mesalazine Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Mesalazine Sales Value and Sales Volume
- 6.2.1 Key Countries/Regions Mesalazine Sales Value, 2020-2031
- 6.2.2 Key Countries/Regions Mesalazine Sales Volume, 2020-2031
6.3 United States
- 6.3.1 United States Mesalazine Sales Value, 2020-2031
- 6.3.2 United States Mesalazine Sales Value by Purity (%), 2024 VS 2031
- 6.3.3 United States Mesalazine Sales Value by Application, 2024 VS 2031
6.4 Europe
- 6.4.1 Europe Mesalazine Sales Value, 2020-2031
- 6.4.2 Europe Mesalazine Sales Value by Purity (%), 2024 VS 2031
- 6.4.3 Europe Mesalazine Sales Value by Application, 2024 VS 2031
6.5 China
- 6.5.1 China Mesalazine Sales Value, 2020-2031
- 6.5.2 China Mesalazine Sales Value by Purity (%), 2024 VS 2031
- 6.5.3 China Mesalazine Sales Value by Application, 2024 VS 2031
6.6 Japan
- 6.6.1 Japan Mesalazine Sales Value, 2020-2031
- 6.6.2 Japan Mesalazine Sales Value by Purity (%), 2024 VS 2031
- 6.6.3 Japan Mesalazine Sales Value by Application, 2024 VS 2031
6.7 South Korea
- 6.7.1 South Korea Mesalazine Sales Value, 2020-2031
- 6.7.2 South Korea Mesalazine Sales Value by Purity (%), 2024 VS 2031
- 6.7.3 South Korea Mesalazine Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
- 6.8.1 Southeast Asia Mesalazine Sales Value, 2020-2031
- 6.8.2 Southeast Asia Mesalazine Sales Value by Purity (%), 2024 VS 2031
- 6.8.3 Southeast Asia Mesalazine Sales Value by Application, 2024 VS 2031
6.9 India
- 6.9.1 India Mesalazine Sales Value, 2020-2031
- 6.9.2 India Mesalazine Sales Value by Purity (%), 2024 VS 2031
- 6.9.3 India Mesalazine Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 PharmaZell
- 7.1.1 PharmaZell Company Information
- 7.1.2 PharmaZell Introduction and Business Overview
- 7.1.3 PharmaZell Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 PharmaZell Mesalazine Product Offerings
- 7.1.5 PharmaZell Recent Development
7.2 Syntese A/S
- 7.2.1 Syntese A/S Company Information
- 7.2.2 Syntese A/S Introduction and Business Overview
- 7.2.3 Syntese A/S Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Syntese A/S Mesalazine Product Offerings
- 7.2.5 Syntese A/S Recent Development
7.3 Cambrex Corporation
- 7.3.1 Cambrex Corporation Company Information
- 7.3.2 Cambrex Corporation Introduction and Business Overview
- 7.3.3 Cambrex Corporation Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Cambrex Corporation Mesalazine Product Offerings
- 7.3.5 Cambrex Corporation Recent Development
7.4 Divis Laboratories
- 7.4.1 Divis Laboratories Company Information
- 7.4.2 Divis Laboratories Introduction and Business Overview
- 7.4.3 Divis Laboratories Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Divis Laboratories Mesalazine Product Offerings
- 7.4.5 Divis Laboratories Recent Development
7.5 Chemi SpA
- 7.5.1 Chemi SpA Company Information
- 7.5.2 Chemi SpA Introduction and Business Overview
- 7.5.3 Chemi SpA Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Chemi SpA Mesalazine Product Offerings
- 7.5.5 Chemi SpA Recent Development
7.6 Ipca Laboratories
- 7.6.1 Ipca Laboratories Company Information
- 7.6.2 Ipca Laboratories Introduction and Business Overview
- 7.6.3 Ipca Laboratories Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Ipca Laboratories Mesalazine Product Offerings
- 7.6.5 Ipca Laboratories Recent Development
7.7 Hangzhou Brother
- 7.7.1 Hangzhou Brother Company Information
- 7.7.2 Hangzhou Brother Introduction and Business Overview
- 7.7.3 Hangzhou Brother Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 Hangzhou Brother Mesalazine Product Offerings
- 7.7.5 Hangzhou Brother Recent Development
7.8 Lianyungang Fengheng Biopharm
- 7.8.1 Lianyungang Fengheng Biopharm Company Information
- 7.8.2 Lianyungang Fengheng Biopharm Introduction and Business Overview
- 7.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Offerings
- 7.8.5 Lianyungang Fengheng Biopharm Recent Development
7.9 Lasa Loboratory
- 7.9.1 Lasa Loboratory Company Information
- 7.9.2 Lasa Loboratory Introduction and Business Overview
- 7.9.3 Lasa Loboratory Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 Lasa Loboratory Mesalazine Product Offerings
- 7.9.5 Lasa Loboratory Recent Development
7.10 Corden Pharma Bergamo
- 7.10.1 Corden Pharma Bergamo Company Information
- 7.10.2 Corden Pharma Bergamo Introduction and Business Overview
- 7.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.10.4 Corden Pharma Bergamo Mesalazine Product Offerings
- 7.10.5 Corden Pharma Bergamo Recent Development
7.11 Erregierre SpA
- 7.11.1 Erregierre SpA Company Information
- 7.11.2 Erregierre SpA Introduction and Business Overview
- 7.11.3 Erregierre SpA Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.11.4 Erregierre SpA Mesalazine Product Offerings
- 7.11.5 Erregierre SpA Recent Development
7.12 CTX Lifescience
- 7.12.1 CTX Lifescience Company Information
- 7.12.2 CTX Lifescience Introduction and Business Overview
- 7.12.3 CTX Lifescience Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.12.4 CTX Lifescience Mesalazine Product Offerings
- 7.12.5 CTX Lifescience Recent Development
7.13 Ishita Active Pharma Ingredients
- 7.13.1 Ishita Active Pharma Ingredients Company Information
- 7.13.2 Ishita Active Pharma Ingredients Introduction and Business Overview
- 7.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.13.4 Ishita Active Pharma Ingredients Mesalazine Product Offerings
- 7.13.5 Ishita Active Pharma Ingredients Recent Development
7.14 YC Biotech (Jiangsu)
- 7.14.1 YC Biotech (Jiangsu) Company Information
- 7.14.2 YC Biotech (Jiangsu) Introduction and Business Overview
- 7.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.14.4 YC Biotech (Jiangsu) Mesalazine Product Offerings
- 7.14.5 YC Biotech (Jiangsu) Recent Development

8 Industry Chain Analysis

8.1 Mesalazine Industrial Chain
8.2 Mesalazine Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
- 8.5.1 Mesalazine Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Mesalazine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
  - 10.1.1.1 Research Programs/Design
  - 10.1.1.2 Market Size Estimation
  - 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
  - 10.1.2.1 Secondary Sources
  - 10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables

Table 1. Mesalazine Market Trends
Table 2. Mesalazine Market Drivers & Opportunity
Table 3. Mesalazine Market Challenges
Table 4. Mesalazine Market Restraints
Table 5. Global Mesalazine Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Mesalazine Revenue Market Share by Company (2020-2025)
Table 7. Global Mesalazine Sales Volume by Company (2020-2025) & (Tons)
Table 8. Global Mesalazine Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Mesalazine Price by Company (2020-2025) & (US$/kg)
Table 10. Key Manufacturers Mesalazine Manufacturing Base and Headquarters
Table 11. Key Manufacturers Mesalazine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Mesalazine
Table 13. Global Mesalazine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Mesalazine Sales Value by Purity: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Mesalazine Sales Value by Purity (2020-2025) & (US$ Million)
Table 18. Global Mesalazine Sales Value by Purity (2026-2031) & (US$ Million)
Table 19. Global Mesalazine Sales Market Share in Value by Purity (2020-2025)
Table 20. Global Mesalazine Sales Market Share in Value by Purity (2026-2031)
Table 21. Global Mesalazine Sales Volume by Purity: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Mesalazine Sales Volume by Purity (2020-2025) & (Tons)
Table 23. Global Mesalazine Sales Volume by Purity (2026-2031) & (Tons)
Table 24. Global Mesalazine Sales Market Share in Volume by Purity (2020-2025)
Table 25. Global Mesalazine Sales Market Share in Volume by Purity (2026-2031)
Table 26. Global Mesalazine Price by Purity (2020-2025) & (US$/kg)
Table 27. Global Mesalazine Price by Purity (2026-2031) & (US$/kg)
Table 28. Global Mesalazine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Mesalazine Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Mesalazine Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Mesalazine Sales Market Share in Value by Application (2020-2025)
Table 32. Global Mesalazine Sales Market Share in Value by Application (2026-2031)
Table 33. Global Mesalazine Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
Table 34. Global Mesalazine Sales Volume by Application (2020-2025) & (Tons)
Table 35. Global Mesalazine Sales Volume by Application (2026-2031) & (Tons)
Table 36. Global Mesalazine Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Mesalazine Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Mesalazine Price by Application (2020-2025) & (US$/kg)
Table 39. Global Mesalazine Price by Application (2026-2031) & (US$/kg)
Table 40. Global Mesalazine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Mesalazine Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Mesalazine Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Mesalazine Sales Value by Region (2020-2025) & (%)
Table 44. Global Mesalazine Sales Value by Region (2026-2031) & (%)
Table 45. Global Mesalazine Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
Table 46. Global Mesalazine Sales Volume by Region (2020-2025) & (Tons)
Table 47. Global Mesalazine Sales Volume by Region (2026-2031) & (Tons)
Table 48. Global Mesalazine Sales Volume by Region (2020-2025) & (%)
Table 49. Global Mesalazine Sales Volume by Region (2026-2031) & (%)
Table 50. Global Mesalazine Average Price by Region (2020-2025) & (US$/kg)
Table 51. Global Mesalazine Average Price by Region (2026-2031) & (US$/kg)
Table 52. Key Countries/Regions Mesalazine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Mesalazine Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Mesalazine Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Mesalazine Sales Volume, (2020-2025) & (Tons)
Table 56. Key Countries/Regions Mesalazine Sales Volume, (2026-2031) & (Tons)
Table 57. PharmaZell Company Information
Table 58. PharmaZell Introduction and Business Overview
Table 59. PharmaZell Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 60. PharmaZell Mesalazine Product Offerings
Table 61. PharmaZell Recent Development
Table 62. Syntese A/S Company Information
Table 63. Syntese A/S Introduction and Business Overview
Table 64. Syntese A/S Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 65. Syntese A/S Mesalazine Product Offerings
Table 66. Syntese A/S Recent Development
Table 67. Cambrex Corporation Company Information
Table 68. Cambrex Corporation Introduction and Business Overview
Table 69. Cambrex Corporation Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 70. Cambrex Corporation Mesalazine Product Offerings
Table 71. Cambrex Corporation Recent Development
Table 72. Divis Laboratories Company Information
Table 73. Divis Laboratories Introduction and Business Overview
Table 74. Divis Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. Divis Laboratories Mesalazine Product Offerings
Table 76. Divis Laboratories Recent Development
Table 77. Chemi SpA Company Information
Table 78. Chemi SpA Introduction and Business Overview
Table 79. Chemi SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 80. Chemi SpA Mesalazine Product Offerings
Table 81. Chemi SpA Recent Development
Table 82. Ipca Laboratories Company Information
Table 83. Ipca Laboratories Introduction and Business Overview
Table 84. Ipca Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 85. Ipca Laboratories Mesalazine Product Offerings
Table 86. Ipca Laboratories Recent Development
Table 87. Hangzhou Brother Company Information
Table 88. Hangzhou Brother Introduction and Business Overview
Table 89. Hangzhou Brother Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 90. Hangzhou Brother Mesalazine Product Offerings
Table 91. Hangzhou Brother Recent Development
Table 92. Lianyungang Fengheng Biopharm Company Information
Table 93. Lianyungang Fengheng Biopharm Introduction and Business Overview
Table 94. Lianyungang Fengheng Biopharm Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 95. Lianyungang Fengheng Biopharm Mesalazine Product Offerings
Table 96. Lianyungang Fengheng Biopharm Recent Development
Table 97. Lasa Loboratory Company Information
Table 98. Lasa Loboratory Introduction and Business Overview
Table 99. Lasa Loboratory Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 100. Lasa Loboratory Mesalazine Product Offerings
Table 101. Lasa Loboratory Recent Development
Table 102. Corden Pharma Bergamo Company Information
Table 103. Corden Pharma Bergamo Introduction and Business Overview
Table 104. Corden Pharma Bergamo Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 105. Corden Pharma Bergamo Mesalazine Product Offerings
Table 106. Corden Pharma Bergamo Recent Development
Table 107. Erregierre SpA Company Information
Table 108. Erregierre SpA Introduction and Business Overview
Table 109. Erregierre SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 110. Erregierre SpA Mesalazine Product Offerings
Table 111. Erregierre SpA Recent Development
Table 112. CTX Lifescience Company Information
Table 113. CTX Lifescience Introduction and Business Overview
Table 114. CTX Lifescience Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 115. CTX Lifescience Mesalazine Product Offerings
Table 116. CTX Lifescience Recent Development
Table 117. Ishita Active Pharma Ingredients Company Information
Table 118. Ishita Active Pharma Ingredients Introduction and Business Overview
Table 119. Ishita Active Pharma Ingredients Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 120. Ishita Active Pharma Ingredients Mesalazine Product Offerings
Table 121. Ishita Active Pharma Ingredients Recent Development
Table 122. YC Biotech (Jiangsu) Company Information
Table 123. YC Biotech (Jiangsu) Introduction and Business Overview
Table 124. YC Biotech (Jiangsu) Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 125. YC Biotech (Jiangsu) Mesalazine Product Offerings
Table 126. YC Biotech (Jiangsu) Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Mesalazine Downstream Customers
Table 130. Mesalazine Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Mesalazine Product Picture
Figure 2. Global Mesalazine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Mesalazine Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Mesalazine Sales Volume (2020-2031) & (Tons)
Figure 5. Global Mesalazine Sales Price (2020-2031) & (US$/kg)
Figure 6. Mesalazine Report Years Considered
Figure 7. Global Mesalazine Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Mesalazine Players Sales Volume Ranking (2024) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mesalazine Revenue in 2024
Figure 10. Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Purity >= 97% Picture
Figure 12. Purity >= 98% Picture
Figure 13. Purity >= 99% Picture
Figure 14. Global Mesalazine Sales Value by Purity (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Mesalazine Sales Value Market Share by Purity, 2024 & 2031
Figure 16. Global Mesalazine Sales Volume by Purity (2020 VS 2024 VS 2031) & (Tons)
Figure 17. Global Mesalazine Sales Volume Market Share by Purity, 2024 & 2031
Figure 18. Global Mesalazine Price by Purity (2020-2031) & (US$/kg)
Figure 19. Product Picture of Tablets
Figure 20. Product Picture of Capsules
Figure 21. Product Picture of Granule
Figure 22. Product Picture of Suppository
Figure 23. Product Picture of Enema
Figure 24. Product Picture of Others
Figure 25. Global Mesalazine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 26. Global Mesalazine Sales Value Market Share by Application, 2024 & 2031
Figure 27. Global Mesalazine Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
Figure 28. Global Mesalazine Sales Volume Market Share by Application, 2024 & 2031
Figure 29. Global Mesalazine Price by Application (2020-2031) & (US$/kg)
Figure 30. North America Mesalazine Sales Value (2020-2031) & (US$ Million)
Figure 31. North America Mesalazine Sales Value by Country (%), 2024 VS 2031
Figure 32. Europe Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 33. Europe Mesalazine Sales Value by Country (%), 2024 VS 2031
Figure 34. Asia Pacific Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Mesalazine Sales Value by Region (%), 2024 VS 2031
Figure 36. South America Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 37. South America Mesalazine Sales Value by Country (%), 2024 VS 2031
Figure 38. Middle East & Africa Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 39. Middle East & Africa Mesalazine Sales Value by Country (%), 2024 VS 2031
Figure 40. Key Countries/Regions Mesalazine Sales Value (%), (2020-2031)
Figure 41. Key Countries/Regions Mesalazine Sales Volume (%), (2020-2031)
Figure 42. United States Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 43. United States Mesalazine Sales Value by Purity (%), 2024 VS 2031
Figure 44. United States Mesalazine Sales Value by Application (%), 2024 VS 2031
Figure 45. Europe Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 46. Europe Mesalazine Sales Value by Purity (%), 2024 VS 2031
Figure 47. Europe Mesalazine Sales Value by Application (%), 2024 VS 2031
Figure 48. China Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 49. China Mesalazine Sales Value by Purity (%), 2024 VS 2031
Figure 50. China Mesalazine Sales Value by Application (%), 2024 VS 2031
Figure 51. Japan Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 52. Japan Mesalazine Sales Value by Purity (%), 2024 VS 2031
Figure 53. Japan Mesalazine Sales Value by Application (%), 2024 VS 2031
Figure 54. South Korea Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 55. South Korea Mesalazine Sales Value by Purity (%), 2024 VS 2031
Figure 56. South Korea Mesalazine Sales Value by Application (%), 2024 VS 2031
Figure 57. Southeast Asia Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 58. Southeast Asia Mesalazine Sales Value by Purity (%), 2024 VS 2031
Figure 59. Southeast Asia Mesalazine Sales Value by Application (%), 2024 VS 2031
Figure 60. India Mesalazine Sales Value, (2020-2031) & (US$ Million)
Figure 61. India Mesalazine Sales Value by Purity (%), 2024 VS 2031
Figure 62. India Mesalazine Sales Value by Application (%), 2024 VS 2031
Figure 63. Mesalazine Industrial Chain
Figure 64. Mesalazine Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed